Skip to content

Tandem Diabetes Care TNDM Free cash flow margin

Free cash flow margin at other companies

Insulet logo
InsuletPODD
14.3%+1.1pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
AdaptHealth logo
AdaptHealthAHCO
5.8%-2.6pp
Mannkind logo
MannkindMNKD
13.8%
Abbott logo
AbbottABT
16.3%+0.6pp
Omnicell logo
OmnicellOMCL
9.3%-1.7pp

Other financials

Income statement

See full
Revenue$247.2M+5.5%
Gross profit$136.8M+15.5%
Operating income-$17.4M+85.6%
Net income-$20.4M+84.4%
EPS (diluted)-$0.30+84.8%

Balance sheet

See full
Cash & equivalents$179.3M+235%
Total debt$734.7M+49.0%
Total equity$132.4M-14.7%
Total assets$1.2B+25.1%

Cash flow

See full
Operating cash flow$11.1M+160%
CapEx$6.3M+111%
Free cash flow$4.8M+123%

Valuation

See full
Market cap$1.03B-23.6%
Enterprise value$1.58B-11.3%
P/S-0.4×

Profitability

See full
Gross margin54.9%+2.7pp
Operating margin-8.2%-2.9pp
Net margin-9.2%-3.1pp

Returns & leverage

See full
Return on equity-65.7%-14.7pp
Debt / equity5.5×+2.4×
Current ratio3.6×+1.3×

Where this comes from

Calculated from Tandem Diabetes Care’s reported figures.

Based on trailing twelve months.

The official record: Tandem Diabetes Care’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Tandem Diabetes Care's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tandem Diabetes Care's free cash flow margin?
Tandem Diabetes Care (TNDM) reported free cash flow margin of -0.8% in Q2 2025.
How has Tandem Diabetes Care's free cash flow margin changed year-over-year?
Tandem Diabetes Care's free cash flow margin increased by 85.3% year-over-year, from -5.3% to -0.8%.
What is the long-term trend for Tandem Diabetes Care's free cash flow margin?
Over 2 years (2021 to 2024), Tandem Diabetes Care's free cash flow margin has grown at a -80.4% compound annual growth rate (CAGR), from 13.8% to 0.5%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.